Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
07/10/2003 | WO2003056295A2 Enterococcal virulence factors |
07/10/2003 | WO2003056024A1 Processes for producing coenzyme q10 |
07/10/2003 | WO2003056023A1 Double-stranded cyclic dna capable of proliferating as artificial e. coli chromosome |
07/10/2003 | WO2003056021A2 Modified tetracycline repressor protein compositions and methods of use |
07/10/2003 | WO2003056020A2 Expression vectors and promoters for heterologous gene expression |
07/10/2003 | WO2003056018A1 Pyroglutamyl peptidase and its gene |
07/10/2003 | WO2003056017A2 Alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said alkaline protease |
07/10/2003 | WO2003056016A1 Fungus-origin lysyl oxidases |
07/10/2003 | WO2003056012A1 A system for stable expression of sirnas in mammalian cells |
07/10/2003 | WO2003056008A1 Regulation of the expression of bacterial motility-associated genes |
07/10/2003 | WO2003055998A2 Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase |
07/10/2003 | WO2003055996A1 Eubacterial rna-polymerase mutants with altered product production |
07/10/2003 | WO2003055994A1 Hxhv virus, nucleic material, peptide material and uses |
07/10/2003 | WO2003055987A1 Novel lactobacillus sp. strain and use thereof |
07/10/2003 | WO2003055986A1 Microorganism overproducing 5'-xanthylic acid |
07/10/2003 | WO2003055985A1 Novel microorganism |
07/10/2003 | WO2003055984A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
07/10/2003 | WO2003055980A2 Il-17 like molecules and uses thereof |
07/10/2003 | WO2003055976A2 Apparatus and method for rapid disruption of cells or viruses |
07/10/2003 | WO2003055974A2 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
07/10/2003 | WO2003055916A2 Adiponectin fragments and conjugates |
07/10/2003 | WO2003055915A2 Human netrin receptor and uses thereof |
07/10/2003 | WO2003055913A2 Secreted protein |
07/10/2003 | WO2003055912A2 Secreted proteins |
07/10/2003 | WO2003055911A2 Cystine-knot fold protein |
07/10/2003 | WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof |
07/10/2003 | WO2003055906A1 Modified bacterial surface layer proteins |
07/10/2003 | WO2003055440A2 Compositions and methods for the treatement of immune related diseases |
07/10/2003 | WO2003033677A3 Dimerized growth factor and materials and methods for producing it |
07/10/2003 | WO2003027245A3 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE |
07/10/2003 | WO2003023030A3 Aminopeptidase |
07/10/2003 | WO2003020959A8 Products containing quantum of bioparticles and method for production thereof |
07/10/2003 | WO2003008636A3 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection |
07/10/2003 | WO2003008452A3 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
07/10/2003 | WO2003007880A3 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
07/10/2003 | WO2003002749A3 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
07/10/2003 | WO2003000861A3 Eukaryotic genes involved in adult lifespan regulation |
07/10/2003 | WO2002092625A3 Moraxella(branhamella) catarrhalis antigens |
07/10/2003 | WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap) |
07/10/2003 | WO2002086154A3 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages |
07/10/2003 | WO2002081727A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
07/10/2003 | WO2002079394A3 Synthesis and use of glycodendrimer reagents |
07/10/2003 | WO2002063008A3 Intracellular signaling molecules |
07/10/2003 | WO2002059326A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
07/10/2003 | WO2002059267A3 Constitutively desensitized g protein-coupled receptors |
07/10/2003 | WO2002057310A3 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
07/10/2003 | WO2002046409A3 Proteins and nucleic acids encoding same |
07/10/2003 | WO2002046238A3 Rationally designed antibodies |
07/10/2003 | WO2002042463A3 Compositions and methods relating to prostate specific genes and proteins |
07/10/2003 | WO2002040541A3 Transporters and ion channels |
07/10/2003 | WO2002040538A8 Regulation of human nmda receptor |
07/10/2003 | WO2002018581A3 G-protein coupled receptors |
07/10/2003 | WO2002018577A9 48921, a novel human gtp releasing factor and uses therefor |
07/10/2003 | WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
07/10/2003 | WO2001096523A3 Polynucleotides related to colon cancer |
07/10/2003 | US20030131382 Chimera gene coding; transgenic plant |
07/10/2003 | US20030131380 Coffee mannanase |
07/10/2003 | US20030131378 Binding toxin to insects; prevent insect resistance |
07/10/2003 | US20030130483 Amino acid sequences free of signal peptide, encoded by cDNA; fusion proteins |
07/10/2003 | US20030130218 Methods of stimulating phagocytosis |
07/10/2003 | US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof |
07/10/2003 | US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/10/2003 | US20030129734 Copper tolerant yeast and pectinases produced by the yeast |
07/10/2003 | US20030129733 Inactivated genomes of diploid microorganisms which are inducible into haploid forms; drug screening |
07/10/2003 | US20030129731 Comprises carrageenan as gelling factor |
07/10/2003 | US20030129727 Nucleic acid encoding 5'-3' exonuclease of bacteriophage RM 378 |
07/10/2003 | US20030129723 Derived from Pyrococcus; genetic engineering; improved heat resistance |
07/10/2003 | US20030129721 Isolated from methylomonas encoding 2-keto-3-deoxy-6-phosphogluconate/fructose bisphosphate aldolase; pyrophosphate dependent phosphofructokinases |
07/10/2003 | US20030129718 Amylase variants |
07/10/2003 | US20030129715 Acid-tolerant homolactic bacteria capable of producing high levels of free lactic acid |
07/10/2003 | US20030129711 Tryptophan biosynthetic enzymes |
07/10/2003 | US20030129710 Novel thermostable isomerase and use hereof, in particular for producing tagatose |
07/10/2003 | US20030129709 In a single reaction, the primer is annealed to the target DNA and extended in an extension/polymerization reaction to produce copies of the target DNA comprising the primer. |
07/10/2003 | US20030129708 The amino acid sequence corresponding to positions from 947 to 951 in a wild type carbamoylphosphate synthetase is replaced, and feedback inhibition by uridine 5'-monophosphate in the bacterium is desensitized. |
07/10/2003 | US20030129706 Fhm, a novel member of the TNF ligand supergene family |
07/10/2003 | US20030129703 Modified dorsal tissue affecting factor and compositions |
07/10/2003 | US20030129698 Involved in homo and heterotrimerization or oligomerization |
07/10/2003 | US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis |
07/10/2003 | US20030129696 Polynucleotides and polypeptides encoding receptors |
07/10/2003 | US20030129688 Heregulin variants |
07/10/2003 | US20030129686 Novel nucleic acid and polypeptide molecules |
07/10/2003 | US20030129663 Methods and compositions for modulating oxidized ldl transport |
07/10/2003 | US20030129655 Nucleic acids encoding GTPase activating proteins |
07/10/2003 | US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity |
07/10/2003 | US20030129644 Used in gene therapy |
07/10/2003 | US20030129636 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
07/10/2003 | US20030129635 Polynucleotide comprising the complete aveC ORF of S. avermitilis, that lacks the next complete ORF that is located downstream from the aveC ORF in situ in the S. avermitilis chromosome. |
07/10/2003 | US20030129633 A helicase unwinds the DNA, a replicase synthesizes new DNA, and primase repeatedly synthesizes new primed starts on the lagging strand. |
07/10/2003 | US20030129614 Providing a porous support that deactivates a nucleic acid amplification inhibitor and directing a fluid through the porous support to separate out the nucleic acid component |
07/10/2003 | US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
07/10/2003 | US20030129586 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase. |
07/10/2003 | US20030129582 Method for determining early HCV seroconversion |
07/10/2003 | US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
07/10/2003 | US20030129197 Influenza vaccine |
07/10/2003 | US20030129185 Chimeric antibodies; lymphocytes; genetic engineering; for treatment of myeloma |
07/10/2003 | US20030129176 Atherosclerosis-associated genes |
07/10/2003 | US20030129165 Direct-fed microbial |
07/10/2003 | CA2471920A1 Improved structured-functional bonding matrices for biomolecules |
07/10/2003 | CA2471916A1 Modified bacterial surface layer proteins |
07/10/2003 | CA2471333A1 Modified tetracycline repressor protein compositions and methods of use |